Xing L, Pan Y, Shi Y, Shu Y, et al. Biomarkers of osimertinib response in patients with refractory, EGFR-T790M-positive non-small cell lung cancer and central nervous system metastases:the APOLLO study. Clin Cancer Res 2020 Aug 17. pii: 1078-0432.CCR-20-2081.
PMID: 32817079